ArticleFrontiers in neurology2025
Use of nutritional supplements and other complementary medicine methods among patients with Parkinson's disease in Lithuania.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary supplements for Parkinson's disease: State of the science.Journal of Parkinson's disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: More than half of Parkinson's (PD) disease patients use nutritional supplements and other methods of complementary medicine (CAM). Only a minority discuss their use with their physician. We aimed to evaluate the prevalence and factors associated with using CAM and nutritional supplements among PD patients in Lithuania. Methods: The cross-sectional study was conducted at Vilnius University Hospital Santaros Klinikos in 2022. Patients diagnosed with PD were asked to complete the questionnaire about nutritional supplements and CAMs used during the past 12 months. Results: The data analysis included 169 out of 206 questionnaires. There were 81 (47.9%) males and 88 (52.1%) females. The median age was 66 years old (IQR 59.5-72), and the median duration of PD was 4 years (IQR 2-8). One hundred six patients (62.7%) took nutritional supplements during the last 12 months, and 52 (30.8%) have used some other kind of CAM. Females used such treatment more often than males, respectively, 70.5% vs. 54.3%, Conclusion: Nutritional supplements and CAM therapies are frequently used by PD patients in Lithuania, with a higher prevalence among females. While 67.3% of CAM users discussed their usage with a treating physician or neurologist, only 47.1% of nutritional supplement users did the same. Nevertheless, the latter has a greater potential for interaction with conventional treatments. There is a need to expand the education of general practitioners, neurologists, and PD patients about the indications, effects, and possible side effects of nutritional supplements and other CAM methods, thus raising awareness and encouraging better communication regarding these measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.